Overview

Dear colleagues,

The Division of Hematology at the University of Colorado Anschutz Medical Campus invites you to attend the 2025 Denver ASH Review conference on Saturday, February 8, 2025. This hybrid one-day continuing education conference will be held from 8:00 a.m. to 12:30 p.m., providing healthcare workers with the most recent updates on blood cancer and blood disorder care. Breakfast and lunch are complimentary.

Location: Hybrid: University of Colorado Anschutz Campus / Zoom
**Building location and Zoom link provided upon registration

Please reach out to Rachel.Anderson@CUAnschutz.edu for questions.

Please register on the website https://denverashreview.com/

Password (all lowercase): dar25

Learning Objectives

By the end of the review, attendees will be better equipped to:

1. Identify which patients with hematologic malignancies would benefit from specific targeted therapies.
2. Recognize a myriad of presentations of patients with hematologic malignancies.
3. Identify higher-risk patients with hematologic malignancies and appropriate therapies for these patients.
4. Identify the best approach to patients requiring more aggressive treatment.
5. Identify complications of hematologic malignancies and their appropriate management in an outpatient setting.
6. Review the diagnosis and treatment of benign hematologic diseases such as sickle cell anemia, coagulopathies, and autoimmune hemolytic anemias.

Accreditation

The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.